LeMaitre Vascular (NASDAQ:LMAT) Now Covered by Wells Fargo & Company

Wells Fargo & Company began coverage on shares of LeMaitre Vascular (NASDAQ:LMAT) in a research note published on Thursday, MarketBeat Ratings reports. The firm issued an equal weight rating and a $95.00 price target on the medical instruments supplier’s stock.

Several other equities research analysts also recently commented on the company. StockNews.com downgraded LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Friday, December 13th. Barrington Research upped their price target on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a research report on Friday, November 1st. Finally, Oppenheimer reiterated an “outperform” rating and issued a $93.00 price target (up previously from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $94.63.

LeMaitre Vascular Stock Performance

LMAT opened at $96.99 on Thursday. The business’s 50-day simple moving average is $96.10 and its 200 day simple moving average is $93.47. The firm has a market capitalization of $2.18 billion, a PE ratio of 53.00, a PEG ratio of 2.19 and a beta of 0.96. LeMaitre Vascular has a 52-week low of $59.04 and a 52-week high of $109.58.

Institutional Investors Weigh In On LeMaitre Vascular

Several hedge funds have recently added to or reduced their stakes in LMAT. New York State Teachers Retirement System raised its position in shares of LeMaitre Vascular by 1.2% in the fourth quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier’s stock valued at $755,000 after purchasing an additional 100 shares during the period. Flputnam Investment Management Co. boosted its holdings in shares of LeMaitre Vascular by 3.6% during the 4th quarter. Flputnam Investment Management Co. now owns 2,923 shares of the medical instruments supplier’s stock worth $269,000 after buying an additional 102 shares during the period. Norden Group LLC grew its stake in LeMaitre Vascular by 4.5% in the 4th quarter. Norden Group LLC now owns 2,371 shares of the medical instruments supplier’s stock valued at $218,000 after buying an additional 103 shares during the last quarter. Blue Barn Wealth LLC raised its holdings in LeMaitre Vascular by 4.4% in the 4th quarter. Blue Barn Wealth LLC now owns 2,485 shares of the medical instruments supplier’s stock valued at $229,000 after acquiring an additional 104 shares during the period. Finally, Shaker Investments LLC OH lifted its position in LeMaitre Vascular by 0.8% during the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier’s stock worth $1,285,000 after acquiring an additional 112 shares during the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.